DMXL2 and chronic myelogenous leukemia, BCR-ABL1 positive: Encouragingly, the results also confirmed that LINC01268, NME8, DMXL2, SCD, and FBN1 were up-regulated while CXXC5 was down-regulated in CML samples (Figure 9A).